1 / 4

Global cancer biomarkers market Competitive Landscape, Trends shaping in Healthcare Developing Business

global cancer biomarkers market is anticipated to expand remarkably at a noteworthy CAGR of 15.8% during the forecast period of 2017-2023.

Rohitravan
Download Presentation

Global cancer biomarkers market Competitive Landscape, Trends shaping in Healthcare Developing Business

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. www.marketresearchfuture.com Global cancer biomarkers market Competitive Landscape, Trends shaping in Healthcare Developing Business P a g e | 1 Copyright © 2017 Market Research Future.

  2. www.marketresearchfuture.com cancer biomarkers market is one of the leading causes of death across the globe. The early stage cancer is diagnosed with the help of biomarkers that are molecules, proteins, or processes indicating the presence of cancerous cells and biological state of tumors in the body. As per the report that has been published by Market Research Future (MRFR), the global cancer biomarkers market is anticipated to expand remarkably at a noteworthy CAGR of 15.8% during the forecast period of 2017-2023. key players in the global cancer biomarkers market that are profiled in the report published by MRFR are F. Hoffmann-La Roche AG (Switzerland), Becton Dickinson (U.S.), Abbott Laboratories (U.S.), PerkinElmer, Inc. (U.S.), Bristol-Myers Squibb (U.S.), Bio-Rad Laboratories (U.S.), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), GlaxoSmithKline Plc. (U.S.), QIAGEN N.V (U.S.), Novartis AG (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Illumina Inc. (U.S.) and others. Get Sample For this Report at: https://www.marketresearchfuture.com/sample_request/6243 Market Segmentation: The global cancer biomarkers market is segmented on the basis of types intoprotein biomarkers, genetic biomarkers and others. Based on application, the cancer biomarkers market is segmented into diagnostic, prognostic and therapeutic. The diagnostic segmented is sub-segmented into imaging and non-imaging. Based on end-users, the cancer biomarkers market is segmented into pharmaceutical and biotechnology companies, diagnostic tool companies, healthcare it/big data companies, clinical laboratories. Market Drivers and Restraints: Rise in prevalence of cancer and extensive research in biomarkers by various research institutes are some of the major factors driving the growth of the global cancer biomarkers market. Extensive application of cancer biomarkers for diagnosis and identification of early-stage cancer, risk assessment, prognosis and treatment predictions, monitoring treatment response and others are fueling the growth of the global cancer biomarkers market. The increasing use of biomarkers in cancer research for development of effective new drugs and increasing application of cancer biomarkers in the area of surrogate endpoints are positively impacting the growth of the global cancer biomarkers market. Proliferation in government initiatives and funding for development of novel cancer diagnostic techniques is acting as one of the major drivers for the expansion of the global cancer biomarkers market. Increasing adoption of advanced technology for research and development of highly effective drugs and accurate diagnosis of cancer are anticipated to fuel the growth of the global cancer biomarkers market. However, high cost of development and validation of biomarkers, reluctance in adoption of advanced technology and low detection rate are likely to act as restraints on the growth of the global cancer biomarkers market. Brows full Detailed copy of Report @ https://www.marketresearchfuture.com/reports/cancer-api-market- 6243 Regional Analysis: The global cancer biomarkers market is regionally segmented into North America, South America, Europe, Asia Pacific and the Middle East and Africa. The North America region is anticipated to account for the largest share in the global cancer biomarkers market owing to the high prevalence of cancer and rapid advancement in the field of cancer biomarkers for development of new drugs and efficient diagnostic procedures in this region. Increasing number of clinical trials and rise in government funding for discovery and development of new biomarkers are leading to the significant growth of the cancer biomarkers market in the Europe region. Whereas, the market in the Asia Pacific region is anticipated to project fastest growth in the global cancer biomarkers market during the forecast period. The cancer biomarkers market in this region is majorly driven by high investments in cancer diagnosis and treatment by public and private sectors and increasing prevalence of cancer. The cancer biomarkers market in the Middle East and Africa region is projecting slow growth owing to the less penetration of advanced diagnostics and treatment facilities and lack of awareness in the underdeveloped areas of this region. Competitive Analysis: P a g e | 2 Copyright © 2017 Market Research Future.

  3. www.marketresearchfuture.com The players in the global cancer biomarkers market are increasing the research and development funding for introducing new biomarkers that would help in accurate diagnosis and development of new drugs for treating cancer. The recent discoveries and developments are strengthening the competition among the players and simultaneously fueling the growth of the global cancer biomarkers market. In July 2018, researchers from University of Delhi and National Institute for Cancer Prevention and Research, Noida (India), have identified two proteins, survivin and STAT3, as potential biomarkers for gastric cancer progression. Inquire for discount at: https://www.marketresearchfuture.com/check-discount/6243 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com P a g e | 3 Copyright © 2017 Market Research Future.

  4. www.marketresearchfuture.com P a g e | 4 Copyright © 2017 Market Research Future.

More Related